Sectoral Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-61,650
Closed -$359K 94
2024
Q4
$359K Sell
61,650
-4,330
-7% -$43.2K 0.24% 63
2024
Q3
$788K Sell
65,980
-52,500
-44% -$671K 0.47% 55
2024
Q2
$1.28M Sell
118,480
-21,500
-15% -$233K 0.52% 51
2024
Q1
$1.58M Buy
139,980
+120,750
+628% +$1.56M 0.62% 50
2023
Q4
$270K Sell
19,230
-418,422
-96% -$5.62M 0.12% 96
2023
Q3
$5.41M Sell
437,652
-210,701
-32% -$2.15M 1.05% 37
2023
Q2
$5.85M Sell
648,353
-347,556
-35% -$2.1M 0.98% 43
2023
Q1
$3.46M Sell
995,909
-445,896
-31% -$1.82M 0.66% 63
2022
Q4
$3.53M Buy
1,441,805
+558,749
+63% +$1.63M 0.68% 63
2022
Q3
$2.44M Buy
+883,056
New +$3.75M 0.48% 71
2021
Q4
Sell
-338,381
Closed -$9.33M 126
2021
Q3
$9.33M Sell
338,381
-151,639
-31% -$4.09M 0.78% 52
2021
Q2
$13.7M Buy
490,020
+477,120
+3,699% +$13.6M 1.11% 34
2021
Q1
$428K Buy
+12,900
New +$553K 0.03% 103

Other funds holding OLMA

Sectoral Asset Management's OLMA Position: Q1 2025 in Review

Sectoral Asset Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2025, closing a stake of 61,650 shares — an estimated $359K sold.

Sectoral Asset Management first reported a position in OLMA in Q1 2021 and held it in 13 quarters. The position peaked at $13.7M in Q2 2021. 133 funds tracked by Wall St. Rank hold OLMA as of Q1 2025.

  • Sectoral Asset Management reported no remaining Olema Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Sectoral Asset Management sold 61,650 Olema Pharmaceuticals shares in Q1 2025, an estimated $359K.
  • Sectoral Asset Management first reported a position in Olema Pharmaceuticals in Q1 2021 and held it in 13 quarters.
  • Sectoral Asset Management's Olema Pharmaceuticals position peaked at $13.7M in Q2 2021.
  • 133 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2025.

Based on Sectoral Asset Management's 13F filing for Q1 2025, filed 15 May 2025.